TrialBritish journal of haematology2019

Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies.

David J Kuter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.